Nanotechnology‐facilitated vaccine development during the coronavirus disease 2019 (COVID‐19) pandemic

Coronavirus disease 2019 (COVID‐19) continually poses a significant threat to the human race, and prophylactic vaccination is the most potent approach to end this pandemic. Nanotechnology is widely adopted during COVID‐19 vaccine development, and the engineering of nanostructured materials such as n...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ziqi, Cui, Kai, Costabel, Ulrich, Zhang, Xiaoju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349967/
https://www.ncbi.nlm.nih.gov/pubmed/35941992
http://dx.doi.org/10.1002/EXP.20210082
_version_ 1784762166628319232
author Wang, Ziqi
Cui, Kai
Costabel, Ulrich
Zhang, Xiaoju
author_facet Wang, Ziqi
Cui, Kai
Costabel, Ulrich
Zhang, Xiaoju
author_sort Wang, Ziqi
collection PubMed
description Coronavirus disease 2019 (COVID‐19) continually poses a significant threat to the human race, and prophylactic vaccination is the most potent approach to end this pandemic. Nanotechnology is widely adopted during COVID‐19 vaccine development, and the engineering of nanostructured materials such as nanoparticles has opened new possibilities in innovative vaccine development by improving the design and accelerating the development process. This review aims to comprehensively understand the current situation and prospects of nanotechnology‐enabled vaccine development against the COVID‐19 pandemic, with an emphasis on the interplay between nanotechnology and the host immune system.
format Online
Article
Text
id pubmed-9349967
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-93499672022-08-04 Nanotechnology‐facilitated vaccine development during the coronavirus disease 2019 (COVID‐19) pandemic Wang, Ziqi Cui, Kai Costabel, Ulrich Zhang, Xiaoju Exploration (Beijing) Reviews Coronavirus disease 2019 (COVID‐19) continually poses a significant threat to the human race, and prophylactic vaccination is the most potent approach to end this pandemic. Nanotechnology is widely adopted during COVID‐19 vaccine development, and the engineering of nanostructured materials such as nanoparticles has opened new possibilities in innovative vaccine development by improving the design and accelerating the development process. This review aims to comprehensively understand the current situation and prospects of nanotechnology‐enabled vaccine development against the COVID‐19 pandemic, with an emphasis on the interplay between nanotechnology and the host immune system. John Wiley and Sons Inc. 2022-07-21 /pmc/articles/PMC9349967/ /pubmed/35941992 http://dx.doi.org/10.1002/EXP.20210082 Text en © 2022 The Authors. Exploration published by Henan University and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Reviews
Wang, Ziqi
Cui, Kai
Costabel, Ulrich
Zhang, Xiaoju
Nanotechnology‐facilitated vaccine development during the coronavirus disease 2019 (COVID‐19) pandemic
title Nanotechnology‐facilitated vaccine development during the coronavirus disease 2019 (COVID‐19) pandemic
title_full Nanotechnology‐facilitated vaccine development during the coronavirus disease 2019 (COVID‐19) pandemic
title_fullStr Nanotechnology‐facilitated vaccine development during the coronavirus disease 2019 (COVID‐19) pandemic
title_full_unstemmed Nanotechnology‐facilitated vaccine development during the coronavirus disease 2019 (COVID‐19) pandemic
title_short Nanotechnology‐facilitated vaccine development during the coronavirus disease 2019 (COVID‐19) pandemic
title_sort nanotechnology‐facilitated vaccine development during the coronavirus disease 2019 (covid‐19) pandemic
topic Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349967/
https://www.ncbi.nlm.nih.gov/pubmed/35941992
http://dx.doi.org/10.1002/EXP.20210082
work_keys_str_mv AT wangziqi nanotechnologyfacilitatedvaccinedevelopmentduringthecoronavirusdisease2019covid19pandemic
AT cuikai nanotechnologyfacilitatedvaccinedevelopmentduringthecoronavirusdisease2019covid19pandemic
AT costabelulrich nanotechnologyfacilitatedvaccinedevelopmentduringthecoronavirusdisease2019covid19pandemic
AT zhangxiaoju nanotechnologyfacilitatedvaccinedevelopmentduringthecoronavirusdisease2019covid19pandemic

Ejemplares similares